Salivary mucins protect surfaces from colonization by cariogenic bacteria

Applied and Environmental Microbiology

Volumn 81, Issue 1, 2015, Pages 332-338

  Frenkel, Erica Shapiro ^a,b   Ribbeck, Katharina ^b  

^a HARVARD UNIVERSITY   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BIOFILMS; BODY FLUIDS; DIAGNOSIS; FLUORESCENCE MICROSCOPY; NETWORK SECURITY; SOLUTIONS; SUGAR (SUCROSE);

ANTI-BIOFOULING; BIOFILM FORMATION; CAVITY FORMATION; DEFENSE MECHANISM; DENTAL CARIES; GASTROINTESTINAL TRACT; STREPTOCOCCUS MUTANS; SURFACE ATTACHMENT;

TOOTH ENAMEL;

BIOFILM; BIOFOULING; CAVITY; COLONIZATION; DENTAL HEALTH; GROWTH RATE; MICROBIAL COMMUNITY; MUCUS; MUTATION; ORGANIC ACID; PROTEIN; SALIVA;

STREPTOCOCCUS MUTANS;

ANTIINFECTIVE AGENT; CARBOXYLIC ACID; MUC5B PROTEIN, HUMAN; MUCIN 5B; SUCROSE;

BACTERIAL COUNT; BACTERIUM ADHERENCE; BIOFILM; CHEMISTRY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; PHYSIOLOGY; SALIVA; STREPTOCOCCUS MUTANS;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; BIOFILMS; CARBOXYLIC ACIDS; COLONY COUNT, MICROBIAL; HUMANS; MICROSCOPY, FLUORESCENCE; MUCIN-5B; SALIVA; STREPTOCOCCUS MUTANS; SUCROSE;

EID: 84917707076     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02573-14     Document Type: Article

References (49)

1. Brockhausen I, Schachter H, Stanley P. 2009. O-GalNAc glycans. In Varki A, Cummings R, Esko J, Freeze H, Stanley P, Bertozzi C, Hart G, Etzler M (ed), Essentials of glycobiology, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
2. Perez-Vilar J, Mabolo R. 2007. Gel-forming mucins. Notions from in vitro studies. Histol Histopathol 22:455-464.
3. Tabak LA. 1995. In defense of the oral cavity: structure, biosynthesis, and function of salivary mucins. Annu Rev Physiol 57:547-564. http://dx.doi.org/10.1146/annurev.ph.57.030195.002555.
4. Van der Sluis M, De Koning B, De Bruijn A, Velcich A, Meijerink J, Van Goudoever J, Büller H, Dekker J, Van Seuningen I, Renes I, Einerhand A. 2006. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131:117-129. http://dx.doi.org/10.1053/j.gastro.2006.04.020.
5. Rose MC, Voynow JA. 2006. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86:245-278. http://dx.doi.org/10.1152/physrev.00010.2005.
6. Derrien M, van Passel MW, van de Bovenkamp JH, Schipper RG, de Vos WM, Dekker J. 2010. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1:254-268. http://dx.doi.org/10.4161/gmic.1.4.12778.
7. Habte HH, Mall AS, de Beer C, Lotz ZE, Kahn D. 2006. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of human immunodeficiency virus type 1 in an inhibition assay. Virol J 3:99. http://dx.doi.org/10.1186/1743-422X-3-99.
8. Bansil R, Turner BS. 2006. Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid Interface Sci 11:164-170. http://dx.doi.org/10.1016/j.cocis.2005.11.001.
9. Veerman EC, Ligtenberg AJ, Schenkels LC, Walgreen-Weterings E, Nieuw Amerongen AV. 1995. Binding of human high-molecular-weight salivary mucins (MG1) to Hemophilus parainfluenzae. J Dent Res 74:351-357. http://dx.doi.org/10.1177/00220345950740011101.
10. Bansil R, Celli JP, Hardcastle JM, Turner BS. 2013. The influence of mucus microstructure and rheology in Helicobacter pylori infection. Front Immunol 4:310. http://dx.doi.org/10.3389/fimmu.2013.00310.
11. Loesche WJ. 1986. Role of Streptococcus mutans in human dental decay. Microbiol Rev 50:353-380.
12. Al-Hashimi I, Levine MJ. 1989. Characterization of in vivo salivaryderived enamel pellicle. Arch Oral Biol 34:289-295. http://dx.doi.org/10.1016/0003-9969(89)90070-8.
13. Cárdenas M, Elofsson U, Lindh L. 2007. Salivary mucin MUC5B could be an important component of in vitro pellicles of human saliva: an in situ ellipsometry and atomic force microscopy study. Biomacromolecules 8:1149-1156. http://dx.doi.org/10.1021/bm061055h.
14. Gibbons RJ, Cohen L, Hay DI. 1986. Strains of Streptococcus mutans and Streptococcus sobrinus attach to different pellicle receptors. Infect Immun 52:555-561.
15. Bushnak IA, Labeed FH, Sear RP, Keddie JL. 2010. Adhesion of microorganisms to bovine submaxillary mucin coatings: effect of coating deposition conditions. Biofouling 26:387-397. http://dx.doi.org/10.1080/08927011003646809.
16. Shi L, Ardehali R, Caldwell KD, Valint P. 2000. Mucin coating on polymeric material surfaces to suppress bacterial adhesion. Colloids Surf B Biointerfaces 17:229-239. http://dx.doi.org/10.1016/S0927-7765(99)00121-6.
17. Kesimer M, Makhov AM, Griffith JD, Verdugo P, Sheehan JK. 2010. Unpacking a gel-forming mucin: a view of MUC5B organization after granular release. Am J Physiol Lung Cell Mol Physiol 298:L15-L22. http://dx.doi.org/10.1152/ajplung.00194.2009.
18. Yakubov GE, Papagiannopoulos A, Rat E, Easton RL, Waigh TA. 2007. Molecular structure and rheological properties of short-side-chain heavily glycosylated porcine stomach mucin. Biomacromolecules 8:3467-3477. http://dx.doi.org/10.1021/bm700607w.
19. Thornton DJ, Khan N, Mehrotra R, Howard M, Sheehan JK, Veerman E, Packer NH. 1999. Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product. Glycobiology 9:293-302. http://dx.doi.org/10.1093/glycob/9.3.293.
20. Andersch-Björkman Y, Thomsson KA, Larsson JMH, Ekerhovd E, Hansson GC. 2007. Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle. Mol Cell Proteomics 6:708-716. http://dx.doi.org/10.1074/mcp.M600439-MCP200.
21. Gerken TA. 1993. Biophysical approaches to salivary mucin structure, conformation and dynamics. Crit Rev Oral Biol Med 4:261-270.
22. Slomiany BL, Murty VLN, Piotrowski J, Slomiany A. 1996. Salivary mucins in oral mucosal defense. Gen Pharmacol Vasc Syst 27:761-771. http://dx.doi.org/10.1016/0306-3623(95)02050-0.
23. Van Klinken BJ, Dekker J, Büller HA, Einerhand AW. 1995. Mucin gene structure and expression: protection vs. adhesion. Am J Physiol 269: G613-G627.
24. Iontcheva I, Oppenheim FG, Troxler RF. 1997. Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins. J Dent Res 76:734-743. http://dx.doi.org/10.1177/00220345970760030501.
25. Tabak LA, Levine MJ, Mandel ID, Ellison SA. 1982. Role of salivary mucins in the protection of the oral cavity. J Oral Pathol 11:1-17. http://dx.doi.org/10.1111/j.1600-0714.1982.tb00138.x.
26. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. 2008. Mucins in the mucosal barrier to infection. Mucosal Immunol 1:183-197. http://dx.doi.org/10.1038/mi.2008.5.
27. Bowen WH, Koo H. 2011. Biology of Streptococcus mutans-derived glucosyltransferases: role in extracellular matrix formation of cariogenic biofilms. Caries Res 45:69-86. http://dx.doi.org/10.1159/000324598.
28. Nakano YJ, Kuramitsu HK. 1992. Mechanism of Streptococcus mutans glucosyltransferases: hybrid-enzyme analysis. J Bacteriol 174:5639-5646.
29. Krzyoeciak W, Jurczak A, Kooecielniak D, Bystrowska B, Skalniak A. 2014. The virulence of Streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis 33:499-515. http://dx.doi.org/10.1007/s10096-013-1993-7.
30. Cross SE, Kreth J, Zhu L, Sullivan R, Shi W, Qi F, Gimzewski JK. 2007. Nanomechanical properties of glucans and associated cell-surface adhesion of Streptococcus mutans probed by atomic force microscopy under in situ conditions. Microbiology 153:3124-3132. http://dx.doi.org/10.1099/mic.0.2007/007625-0.
31. Socransky SS, Haffajee AD. 2002. Dental biofilms: difficult therapeu-tic targets. Periodontol 2000 28:12-55. http://dx.doi.org/10.1034/j.1600-0757.2002.280102.x.
32. Shemesh M, Tam A, Aharoni R, Steinberg D. 2010. Genetic adaptation of Streptococcus mutans during biofilm formation on different types of surfaces. BMC Microbiol 10:51. http://dx.doi.org/10.1186/1471-2180-10-51.
33. Shemesh M, Tam A, Steinberg D. 2007. Expression of biofilm-associated genes of Streptococcus mutans in response to glucose and sucrose. J Med Microbiol 56:1528-1535. http://dx.doi.org/10.1099/jmm.0.47146-0.
34. Koo H, Xiao J, Klein MI, Jeon JG. 2010. Exopolysaccharides produced by Streptococcus mutans glucosyltransferases modulate the establishment of microcolonies within multispecies biofilms. J Bacteriol 192:3024-3032. http://dx.doi.org/10.1128/JB.01649-09.
35. Duarte S, Klein MI, Aires CP, Cury JA, Bowen WH, Koo H. 2008. Influences of starch and sucrose on Streptococcus mutans biofilms. Oral Microbiol Immunol 23:206-212. http://dx.doi.org/10.1111/j.1399-302X.2007.00412.x.
36. Kreth J, Zhu L, Merritt J, Shi W, Qi F. 2008. Role of sucrose in the fitness of Streptococcus mutans. Oral Microbiol Immunol 23:213-219. http://dx.doi.org/10.1111/j.1399-302X.2007.00413.x.
37. McBride BC, Gisslow MT. 1977. Role of sialic acid in saliva-induced aggregation of Streptococcus sanguis. Infect Immun 18:35-40.
38. van Houte PJ. 1982. Bacterial adherence and dental plaque formation. Infection 10:252-260. http://dx.doi.org/10.1007/BF01666923.
39. Levine MJ, Herzberg MC, Levine MS, Ellison SA, Stinson MW, Li HC, van Dyke T. 1978. Specificity of salivary-bacterial interactions: role of terminal sialic acid residues in the interaction of salivary glycoproteins with Streptococcus sanguis and Streptococcus mutans. Infect Immun 19: 107-115.
40. Klein A, Carnoy C, Wieruszeski JM, Strecker G, Strang AM, Van Halbeek H, Roussel P, Lamblin G. 1992. The broad diversity of neutral and sialylated oligosaccharides derived from human salivary mucins. Biochemistry (Mosc) 31:6152-6165. http://dx.doi.org/10.1021/bi00141a028.
41. Williams RC, Gibbons RJ. 1975. Inhibition of streptococcal attachment to receptors on human buccal epithelial cells by antigenically similar salivary glycoproteins. Infect Immun 11:711-718.
42. Thomsson KA, Prakobphol A, Leffler H, Reddy MS, Levine MJ, Fisher SJ, Hansson GC. 2002. The salivary mucin MG1 (MUC5B) carries a repertoire of unique oligosaccharides that is large and diverse. Glycobiology 12:1-14. http://dx.doi.org/10.1093/glycob/12.1.1.
43. Gibbons RJ, Dankers I. 1981. Lectin-like constituents of foods which react with components of serum, saliva, and Streptococcus mutans. Appl Environ Microbiol 41:880-888.
44. Gibbons RJ, Qureshi JV. 1978. Selective binding of blood group-reactive salivary mucins by Streptococcus mutans and other oral organisms. Infect Immun 22:665-671.
45. Murray PA, Prakobphol A, Lee T, Hoover CI, Fisher SJ. 1992. Adherence of oral streptococci to salivary glycoproteins. Infect Immun 60:31-38.
46. Amerongen AVN, Bolscher JGM, Veerman ECI. 1995. Salivary mucins: protective functions in relation to their diversity. Glycobiology 5:733-740. http://dx.doi.org/10.1093/glycob/5.8.733.
47. Schenkels LCPM, Ligtenberg AJM, Veerman ECI, Van Nieum Amerongen A. 1993. Interaction of the salivary glycoprotein EP-GP with the bacterium Streptococcus salivarius HB. J Dent Res 72:1559-1565. http://dx.doi.org/10.1177/00220345930720120501.
48. Xiao J, Koo H. 2010. Structural organization and dynamics of exopolysaccharide matrix and microcolonies formation by Streptococcus mutans in biofilms. J Appl Microbiol 108:2103-2113. http://dx.doi.org/10.1111/j.1365-2672.2009.04616.x.
49. Xiao J, Klein MI, Falsetta ML, Lu B, Delahunty CM, Yates JR, III, Heydorn A, Koo H. 2012. The exopolysaccharide matrix modulates the interaction between 3D architecture and virulence of a mixed-species oral biofilm. PLoS Pathog 8:e1002623. http://dx.doi.org/10.1371/journal.ppat.1002623.